Carolyn V. Gould, MD, MSCR 1; Craig A. Umscheid, MD, MSCE 2; Rajender K. Agarwal, MD, MPH 2; Gretchen Kuntz, MSW, MSLIS 2; David A. Pegues, MD 3 and the Healthcare Infection Control Practices Advisory Committee (HICPAC)4
1Division of Healthcare Quality Promotion
Centers for Disease Control and Prevention
Atlanta, GA
2Center for Evidence-based Practice
University of Pennsylvania Health System
Philadelphia, PA
3Division of Infectious Diseases
David Geffen School of Medicine at UCLA
Los Angeles, CA
4Healthcare Infection Control Practices Advisory Committee (HICPAC)
ChairBRENNAN, Patrick J., MD Executive SecretaryBELL, Michael R., MD MembersBURNS, Lillian A., MPH ELWARD, Alexis, MD, MPH ENGEL, Jeffrey, MD LUNDSTROM, Tammy, MD, JD GORDON, Steven M., MD MCCARTER, Yvette S., PhD Director, Clinical Microbiology |
MURPHY, Denise M., MPH, RN, CIC OLMSTED, Russell N., MPH PEGUES, David Alexander, MD RAMSEY, Keith M., MD SINGH, Nalini, MD, MPH SOULE, Barbara M., RN, MPA, CIC SCHECTER, William, P., MD STEVENSON, Kurt Brown, MD, MPH |
Ex-officio MembersAgency for Healthcare Research and Quality National Institute of Health Health Resources and Services Food and Drug Administration Center for Medicare & Medicaid Services Department of Veterans Affairs (VA) LiaisonsAssociation of Professionals of Infection Council of State and Territorial Epidemiologists |
American Health Care Association American College of Occupational and Advisory Council for the Elimination of American Hospital Association Association of periOperative Registered Society for Healthcare Epidemiology of America Joint Commission on Accreditation of Consumers Union |
Acknowledgement
HICPAC thanks the following members who served on the HICPAC CAUTI Guideline subcommittee during the guideline development process: Russell N. Olmsted, MPH, Yvette S. McCarter, PhD, Barbara M. Soule, RN, MPA, CIC, and Nalini Singh, MD, MPH.
HICPAC thanks the following outside experts for reviewing a draft of this guideline: Edward S. Wong, MD, Lindsay E. Nicolle, MD, Anthony J. Schaeffer, MD, and Harriett M. Pitt, RN, MS, CIC. The opinions o the reviewers might not be reflected in all the recommendations contained in this document.
HICPAC would also like to thank the many individuals and organizations who provided valuable feedback on the guideline during the public comment period.
Disclosure of Financial Interests and Relationships
The authors C.V.G., C.A.U., R.K.A., and G.K. report no actual or potential conflicts of interest. D.A.P. is on the Speakers Bureau of Merck, Pfizer, Schering, and Cubist and is a consultant for Dow Pharmaceuticals, DaVita, and Vasonova. C.A.U. and R.K.A. received funding from the CDC to support the guideline development process.
2009 CAUTI Guidelines (407 KB / 67 pages) and Appendices (4.41 MB / 268 pages) are available for download in PDF format.